Drugs · Entity Annotation Prototype (beta)

7articles mentioning drugs

21drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: RPV ×

RPV

This drug is selected. Its supporting articles are shown below.

RPV7

Articles mentioning RPV

7 articles · page 1 of 1

OC74 Outcomes of cabotegravir-rilpivirine in key groups of people with HIV (PWH): data from the ICONA cohort

sextrans · abstract · 2026-05-20 · 6 matching annotations

84.6%

cabotegravir RPV rilpivirine CAB HIV-RNA ICONA Cohort HIV PWH

…Background The widespread adoption of cabotegravir (CAB)/rilpivirine (RPV) long-acting (LA) in clinical practice m…

OC67 Reasons for discontinuation of single-tablet regimen rilpivirine/emtricitabine/tenofovir alafenamide (RPV/FTC/TAF) in the era of 2nd-generation INSTIs

sextrans · abstract · 2026-06-05 · 5 matching annotations

82.0%

RPV PWH HIV AIDS

…-up since this regimen initiation was 6 (5-7) years.Conclusions RPV/FTC/TAF demonstrated a high virological efficacy and durability…

SC20 Use of next-generation sequencing (NGS) as an additional tool to evaluate suitability of long-acting cabotegravir/rilpivirine treatment and tailoring follow-up

sextrans · abstract · 2026-06-05 · 3 matching annotations

84.6%

rilpivirine RPV cabotegravir RPVAbstract PWH HIV-RNA HIV

…Background Long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV) is an effective and well-tolerated antiretroviral switch …

SC19 Weight and lipid changes after switching to long-acting cabotegravir and rilpivirine

sextrans · abstract · 2026-05-20 · 3 matching annotations

86.9%

cabotegravir rilpivirine RPV CAB RPVAbstract PWH HIV SCOLTA

…Background The long-acting (LA) treatment with cabotegravir (CAB) and rilpivirine (RPV) has been reported to have a neutral…

4CPS-100 Persistence, adherence, and safety of cabotegravir/rilpivirine in people living with HIV

ejhpharm · abstract · 2026-03-18 · 2 matching annotations

80.2%

rilpivirine acenocoumarol cabotegravir RPV HIV PLHIV Long-acting antiretroviral therapy

…adherence, and safety of long-acting intramuscular cabotegravir/rilpivirine (CAB/RPV) in PLHIV.Material and Methods This was a retrospectiv…

P70 Improvement in patient-reported outcomes (PROs) after one year of long-acting cabotegravir and rilpivirine

sextrans · abstract · 2026-06-05 · 1 matching annotations

92.5%

cabotegravir rilpivirine RPV CAB HIV LAI-ART HIV-TSQs EQ-5D

…nter study enrolled PLWH who switched to bimonthly LAI-ART with cabotegravir (CAB) and rilpivirine (RPV) between January 2023 and October 20…

OC73 Intracellular pharmacokinetics and inhibitory quotient of long acting cabotegravir and rilpivirine in the clinical setting

sextrans · abstract · 2026-05-20 · 1 matching annotations

78.4%

Rilpivirine cabotegravir RPV

…t (IQ) over time during follow-up from month 1 to month 31. (a) Rilpivirine IQ, (b) CAB IQ; Linear red solid line represents the IQ cut-off…